CASI News and Press, CASI Pharmaceuticals Inc. From 10/27/20

BioInvent licenses anti-FcγRllB antibody BI-1206 to CASI Pharmaceuticals for Greater China region - CASI's pipeline expanded to include first-in-class monoclonal antibody developed to unlock anti-cancer immunity in liquid and solid tumors - Collaboration accelerates a...

Biotech Penny Stocks To Watch This Week Looking for top penny stocks to watch this week? You’re not alone. One of the hotter sectors to watch in the stock market today is biotech and healthcare. I’m not just saying that because coronavirus vaccines remain a hot button ...

Gainers: Cassava Sciences (SAVA) +13%, Medigus (MDGS) +10%, STRATA Skin Sciences (SSKN) +9%, CASI Pharmaceuticals (CASI) +8%, BOQI International Medical (BIMI) +7%.Losers: Neovasc (NVCN) -14%, ProPhase Labs (PRPH) -14%, Mileston...

CASI Pharmaceuticals Announces Poster Presentation At The 2020 AABB Virtual Annual Meeting PR Newswire ROCKVILLE, Md. and BEIJING, Oct. 2, 2020 ROCKVILLE, Md. and BEIJING , Oct. 2, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S...

CASI Pharmaceuticals ([[CASI]] +2.3%) restructured its partnership with Juventas Cell Therapy relating to CNCT19, an investigational CD19 CAR-T Cell therapy.Post restructuring, Juventas can attract fresh capital to assist in upcoming trials and build out a GMP manufacturing facility for comme...

CASI Pharmaceuticals Announces Restructuring of Partnership with Juventas Cell Therapy Ltd - CASI and Juventas to co-commercialize and co-market CD19 CAR-T (CNCT19) therapy - CASI increases its equity position in Juventas - CASI receives co-commercial rights to second pi...

ROCKVILLE, Md. and BEIJING , Sept. 11, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announced that Dr. Wei-Wu He , Chairman and Chief ...

Crinetics Pharmaceuticals (NASDAQ: CRNX ) announces that a presentation of its orally available small molecule adrenocorticotropic hormone (ACTH) antagonist was selected for a late-breaking session a the virtual European Congress of Endocrinology on September 8. More news on: Crinetics...

Image source: The Motley Fool. CASI Pharmaceuticals Inc   (NASDAQ: CASI) Q2 2020 Earnings Call Aug 10, 2020 , 4:30 p.m. ET Operator Continue reading

CASI Pharmaceuticals, Inc. (CASI) Q2 2020 Results Conference Call August 10, 2020 04:30 PM ET Company Participants Cynthia Hu - General Counsel & Secretary Dr. Wei-Wu He - Chairman and CEO Dr. Alex Zukiwski - Chief Medical Officer Conference Call Participants Nathaniel ...